Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

PerkinElmer Articles

PerkinElmer collaborates with Sth Korean University

23 March 2009

Evotec's 2007 net loss narrows to 11.2M euros

7 April 2008

Evotec 9-month net loss improves to $53.8M

3 December 2007

Evotec swings to 1st-qtr 2007 profit

21 May 2007

Euroscreen sells GPCR products to PerkinElmer

22 January 2007

Stock Commentary - Europe - week to Jan 8, 2007

15 January 2007

Evotec sells Tech unit to PerkinElmer for $30.6M

11 December 2006

PerkinElmer buys Spectral Geno assets

8 May 2006

Stock Commentary - New York

4 July 2005

PerkinElmer completes DSB divestiture

24 June 2002

PerkinElmer planning to acquire NEN Life Sciences for $400 million

13 June 2000

Showing 1-11 of 11 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS